749788
Last Update Posted: 2013-02-04
Recruiting has ended
All Genders accepted | 18 Years-65 Years |
150 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels
The purpose of this study is to determine the effect of JTT-302 on the increase of High Density Lipoprotein-Cholesterol (HDL-C) levels when administered daily for four weeks in subjects with low HDL-C levels.
Eligibility
Relevant conditions:
Dyslipidemia
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov